The marked upregulation of TNF-α in adipose tissue during obesity is a well-established marker of adipose tissue dysfunction and insulin resistance (119), and its attenuation by Andrographolide may contribute to the observed effects on glucose metabolic regulators in VAT. Here, TNF is linked to obesity disorder.